Form 4 for MRNA Moderna
Accepted 2025-02-28 00:00:00 ET · period of report 2025-02-27 · accession 0001127602-25-007277 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-28 | 2025-02-27 | MRNA | Mock James M | CFO | F - Tax | $33.58 | -2,780 | 12.4K | -18% | -$93.4K |
| DM | 2025-02-28 | 2025-02-27 | MRNA | Mock James M | CFO | M - OptEx | — | +5,746 | 13.1K | +79% | — |
| DM | 2025-02-28 | 2025-02-27 | MRNA | Mock James M | CFO | M - OptEx | $0.00 | -5,746 | 9,283 | -38% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-27 | F | D | 1,496 | $33.58 | 14,021 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-27 | M | A | 1,326 | — | 15,347 | D | — | — | (F3) Restricted stock units convert into common stock on a one-for-one basis. |
| 3 | Common | Common Stock | 2025-02-27 | F | D | 642 | $33.58 | 14,705 | D | — | — | |
| 4 | Common | Common Stock | 2025-02-27 | M | A | 3,094 | — | 15,517 | D | — | — | (F3) Restricted stock units convert into common stock on a one-for-one basis. |
| 5 | Common | Common Stock | 2025-02-27 | M | A | 1,326 | — | 13,065 | D | — | — | (F1) Performance stock units convert into common stock on a one-for-one basis. |
| 6 | Common | Common Stock | 2025-02-27 | F | D | 642 | $33.58 | 12,423 | D | — | — | |
| 7 | Derivative | Restricted Stock Units | 2025-02-27 | M | D | 1,326 | $0.00 | 0 | D | — · — to — | 1,326 Common Stock | (F3) Restricted stock units convert into common stock on a one-for-one basis. (F7) 25% of the shares subject to this restricted stock unit award vested on May 27, 2024 with the remainder vesting in three (3) equal quarterly installments thereafter. |
| 8 | Derivative | Performance Stock Units | 2025-02-27 | M | D | 1,326 | $0.00 | 0 | D | — · — to — | 1,326 Common Stock | (F1) Performance stock units convert into common stock on a one-for-one basis. (F5) 25% of the shares subject to this performance stock unit award vested on May 31, 2024 upon determination of achievement of the performance criteria, with the remainder vesting in three (3) equal installments on August 27, 2024, November 27, 2024 and February 27, 2025. |
| 9 | Derivative | Restricted Stock Units | 2025-02-27 | M | D | 3,094 | $0.00 | 9,283 | D | — · — to — | 3,094 Common Stock | (F3) Restricted stock units convert into common stock on a one-for-one basis. (F6) 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |